Ñý¼§Ö±²¥ Vice-Principal ResearchNews
Queen’s alumnus-developed platform myLaminin brings high level of security to Research Data Management
Jul 15, 2025
Queen’s University Life Sciences graduate Ash Bassili’s company myLaminin is set to revolutionize how research data is managed, shared, and secured.
WE-CAN client Tammy Watson wins $10,000 at Equal Slice Pitch Competition
Jun 25, 2025
Tammy Watson, the Canadian Handywoman, is on a Ñý¼§Ö±²¥ to empower women with tools, skills, and community.
Celebrating connection and community at the WE-CAN Mix + Mingle
Jun 16, 2025
On June 3, 2025, women entrepreneurs from across the Kingston area gathered for an in-person WE-CAN Mix + Mingle networking and community event.
QPI-supported Scale Up Platform startups took a deep dive into the differentiation process
Jun 05, 2025
Four of Queen’s Partnerships and Innovation (QPI)’s supported startups recently participated in a dynamic one-day workshop led by Andrew Jackson, the creator of the 5D Differentiation™ framework.
Dynamiris receives CABHI funding to further develop AI-enhanced eye tracking technology
May 27, 2025
Dynamiris Inc. is one of 23 funding recipients of the Centre for Aging + Brain Health Innovation’s (CABHI) Ignite program.
May 6, 2025: Canadian Patent No. 3,013,376 "Method and Apparatus for Acoustic and Tactile Presentation of Chemical Spectrum Data"
May 06, 2025
Queen's Partnerships and Innovation is pleased to report the issuance of Canadian Patent No. 3,013,376
May 6, 2025: Canadian Patent No. 3,022,981 "Hippo Pathway Bioluminescent Biosensor"
May 06, 2025
Queen's Partnerships and Innovation is pleased to report the issuance of Canadian Patent No. 3,022,981
April 29, 2025: U.S. Patent No. 12,286,558 "UV-Curable Anti-Smudge and Anti-Graffiti Compositions"
Apr 29, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,286,558
Glaucoma monitoring device receives CIHR commercialization funding
Apr 28, 2025
Contact lens-based device from Queen’s startup LenSense aims to transform glaucoma management and improve patient outcomes.
April 22, 2025: U.S. Patent No. 12,282,001 "Systems, Devices, and Methods for Electrochemical Water Analysis"
Apr 22, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,282,001
April 15, 2025: U.S. Patent No. 12,278,555 "Variable Gain Modulation Methods and Controllers for AC-DC Converter with Power Factor Correction"
Apr 15, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,278,555
Cntrl+ Inc. receives clearance from the US Food and Drug Administration
Apr 03, 2025
After an arduous journey, Cornwall-based Cntrl+ Inc. officially received clearance from the United States Food and Drug Administration (US FDA) for its reusable female bladder support in December 2024.